May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Clinical Characterization of RP10 in a Large Family With an Identified (Asp226Asn) IMPDH1 Mutation
Author Affiliations & Notes
  • D.K. H. Wheaton
    Retina Foundation of the SW, Dallas, TX
  • P. Kozma
    Retina Foundation of the SW, Dallas, TX
  • G.E. Fish
    Texas Retina Associates, Dallas, TX
  • K.G. Locke
    Retina Foundation of the SW, Dallas, TX
  • S.J. Bowne
    Human Genetics Center, UT–Houston, Houston, TX
  • L.S. Sullivan
    Human Genetics Center, UT–Houston, Houston, TX
  • S.P. Daiger
    Human Genetics Center, UT–Houston, Houston, TX
  • D.G. Birch
    Retina Foundation of the SW, Dallas, TX
    Dept. of Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • Footnotes
    Commercial Relationships  D.K.H. Wheaton, None; P. Kozma, None; G.E. Fish, None; K.G. Locke, None; S.J. Bowne, None; L.S. Sullivan, None; S.P. Daiger, None; D.G. Birch, None.
  • Footnotes
    Support  NIH Grants EY14170, EY05235, and FFB
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 512. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.K. H. Wheaton, P. Kozma, G.E. Fish, K.G. Locke, S.J. Bowne, L.S. Sullivan, S.P. Daiger, D.G. Birch; Clinical Characterization of RP10 in a Large Family With an Identified (Asp226Asn) IMPDH1 Mutation . Invest. Ophthalmol. Vis. Sci. 2005;46(13):512.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate the clinical features associated with the RP10 form of autosomal dominant retinitis pigmentosa (adRP) in individuals with a defined IMPDH1 mutation. Methods: Affected (n=11; 13–60 yrs) and unaffected individuals (n=2; 16 & 24 yrs) from a large family with an Asp226Asn missense mutation were examined. Visual function assessment included visual acuity, color vision, visual field (30–2), dark adaptometry, dark–adapted full–field electroretinography (ffERG), multifocal electroretinography (mfERG), fundus photography, optical coherence tomography (OCT), and a routine ophthalmologic examination. Blood samples were obtained from all participants for basic immune function screening. Patients were divided into two groups based on age for data analysis: teens (n=4; 13–19 yrs) and adults (n=7; ≥20 yrs). Results: Visual acuity was reduced at an early age; affected teens had acuities of 20/32 to 20/100. Visual fields were also markedly constricted (mean=38 degrees) and dark–adapted thresholds were elevated 1.1 log units on average. Visual fields were progressively constricted with age resulting in field ≤20 degrees by age 40 and ≤10 degrees by age 60; dark–adapted thresholds exhibited further elevation (adult mean=1.8 log units). ffERGs were typical of severe RP and included low or non–detectable rod ERGs by age 20 and greater rod than cone loss at all ages. Additional ERG findings in this family were normal to significantly delayed ffERG cone b–wave implicit times that corresponded with implicit times of mfERG responses from the macula. Color defects were observed in 3 individuals (1 teen, 2 adults). OCT revealed foveal swelling in the majority of eyes and cystoid macular edema was diagnosed in 3 individuals. No unusual immunologic findings were noted. Conclusions: The Asp226Asn mutation is associated with a relatively severe, early onset form of retinal degeneration in this family. Visual function measures illustrate significant visual impairment by 20 years of age.

Keywords: retinal degenerations: hereditary • mutations • electroretinography: clinical 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.